Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(166 sites)

United States

Chandler Clinical Research Trials- Site Number : 8400025, Chandler, Arizona

Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix, Arizona

Epic Medical Research - Surprise- Site Number : 8400096, Surprise, Arizona

IMAX Clinical Trials- Site Number : 8400109, La Palma, California

Long Beach Research Institute- Site Number : 8400027, Long Beach, California